LAWSUITS NEWS & LEGAL INFORMATION
Oversized Hydromorphone HCl 2 mg Tablets Prompts Nationwide Recall
ETHEX Corporation in conjunction with the FDA has issued a nationwide recall of a single production lot of Hydromorphone HCl 2 mg tablets (Lot #90219, Exp: 03/2010; NDC #58177-0620-04), due to the possibility it may contain oversized tablets.
If someone were to take a higher than expected dose of Hydromorphone, the risk of adverse effects known to be associated with the drug may be increased, including respiratory depression (difficulty or lack of breathing), low blood pressure, and sedation.
There are other companies in the United States producing and marketing versions of Hydromorphone HCl tablets and consumers and their caregivers are encouraged to check their prescriptions to determine the source of their tablets. Hydromorphone HCl 2 mg tablets marketed by ETHEX are a blue, round tablet with a script "E" on one side and a "2" on the other side.
Published on Dec-24-08
If someone were to take a higher than expected dose of Hydromorphone, the risk of adverse effects known to be associated with the drug may be increased, including respiratory depression (difficulty or lack of breathing), low blood pressure, and sedation.
There are other companies in the United States producing and marketing versions of Hydromorphone HCl tablets and consumers and their caregivers are encouraged to check their prescriptions to determine the source of their tablets. Hydromorphone HCl 2 mg tablets marketed by ETHEX are a blue, round tablet with a script "E" on one side and a "2" on the other side.
Legal Help
If you or a loved one has suffered adverse health effects from using this product, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.Published on Dec-24-08
READ MORE Drugs/Medical Settlements and Legal News